People who have previously received Zostavax can receive Shingrix to increase their protection against herpes zoster, since protection using Zostavax wanes significatnly from around 5 years after vaccination.
The optimal interval between receipt of Zostavax and Shingrix may vary, but an interval of at least 12 months is recommended between receiving Zostavax and a subsequent dose of Shingrix. The person will still need to complete the 2-dose schedule of Shingrix.
If a person has previously received Zostavax through the NIP, they are not eligible to receive Shingrix through the NIP until 5 years after the Zostavax dose. If a person paid privately for a previous dose of Zostavax, they are eligible to receive Shingrix through the NIP at any time after the optimal interval.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.